Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report released on Wednesday. The firm issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ ONCT opened at $0.53 on Wednesday. The firm’s 50-day moving average price is $0.53 and its two-hundred day moving average price […]
More Stories
4 US Soldiers Go Missing in Lithuania During Joint Military Training Exercise
By Chase Smith and Jacob Burg Four U.S. Army soldiers went missing during a scheduled training exercise in Lithuania on...
Trump Announces 25 Percent Tariffs on Foreign Cars
By Andrew Moran President Donald Trump on March 26 announced 25 percent tariffs on foreign cars in a move aimed...
Treasury Department Planning to Fire ‘Substantial’ Number of Workers: Official
By Zachary Stieber The Department of the Treasury is working on plans to fire a substantial number of workers, according...
Researchers Identify Diets in Mid-Life Linked to Healthy Aging
By George Citroner A 30-year study finds a primarily plant-based diet, with minimal ultra-processed food and low to moderate amounts...
Russian Negotiators May Be ‘Dragging Their Feet’ in Ukraine Cease-Fire Talks, Trump Says
By Ryan Morgan Russian negotiators may be intentionally drawing out the talks for a cease-fire after their more than three-year...
Thrivent Financial for Lutherans Sells 355 Shares of Target Co. (NYSE:TGT)
Thrivent Financial for Lutherans cut its holdings in shares of Target Co. (NYSE:TGT – Free Report) by 1.3% during the...